Excalibur Management Corp Raises Holdings in CVS Health Co. (NYSE:CVS)

Excalibur Management Corp lifted its holdings in CVS Health Co. (NYSE:CVS) by 3.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 45,784 shares of the pharmacy operator’s stock after purchasing an additional 1,526 shares during the quarter. CVS Health accounts for about 1.1% of Excalibur Management Corp’s investment portfolio, making the stock its 18th biggest holding. Excalibur Management Corp’s holdings in CVS Health were worth $2,704,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Ables Iannone Moore & Associates Inc. bought a new position in CVS Health during the fourth quarter valued at approximately $32,000. Creekmur Asset Management LLC bought a new stake in shares of CVS Health in the fourth quarter worth $34,000. Steph & Co. increased its position in CVS Health by 192.0% during the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after acquiring an additional 288 shares during the last quarter. Kapitalo Investimentos Ltda bought a new position in CVS Health in the fourth quarter valued at about $36,000. Finally, Scarborough Advisors LLC purchased a new position in CVS Health in the fourth quarter worth about $37,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

CVS Health stock opened at $58.37 on Tuesday. The company’s 50-day moving average price is $58.31 and its 200-day moving average price is $62.88. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83. The company has a market cap of $73.28 billion, a PE ratio of 10.26, a price-to-earnings-growth ratio of 0.79 and a beta of 0.53. CVS Health Co. has a twelve month low of $52.77 and a twelve month high of $83.25.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.10. The company had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. CVS Health’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.21 EPS. On average, equities research analysts forecast that CVS Health Co. will post 6.51 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, August 1st. Investors of record on Monday, July 22nd were issued a dividend of $0.665 per share. The ex-dividend date was Monday, July 22nd. This represents a $2.66 annualized dividend and a yield of 4.56%. CVS Health’s payout ratio is 46.75%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on CVS shares. Deutsche Bank Aktiengesellschaft decreased their price target on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. Baird R W raised CVS Health to a “hold” rating in a report on Thursday, May 30th. Royal Bank of Canada restated an “outperform” rating and set a $68.00 target price on shares of CVS Health in a research note on Wednesday, September 4th. Evercore ISI dropped their price target on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating for the company in a research report on Thursday, August 8th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $62.00 target price on shares of CVS Health in a research note on Monday. Eleven investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $72.10.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.